Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
NCT04721873Phase 2Recruiting
- Sponsor
- University of California, San Diego
- Start
- Dec 2020
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phentermine + topiramate in ulcerative colitis (UC), obesity, sponsored by University of California, San Diego. Started Dec 2020; status: recruiting.
02
Drugs
phentermine + topiramate
03
Conditions
ulcerative colitis (UC)obesity
Beyond the preview
Go deeper on NCT04721873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04721873.